# 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for hypertrophic cardiomyopathy

Guideline · id `cardio:guideline-aha-acc-2024-hcm` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

The 2024 US guideline on the management of hypertrophic cardiomyopathy, issued by the American Heart Association and the American College of Cardiology with four other societies named in its title (AMSSM, HRS, PACES and SCMR). Its abstract says it updates recommendations from the 2020 AHA/ACC guideline with new evidence. Only the abstract could be read, so this page does not give the guideline's recommendations.

## Technical summary

Circulation, 2024. PubMed 38718139, DOI 10.1161/CIR.0000000000001250. The same guideline was published in the Journal of the American College of Cardiology (PubMed 38727647, DOI 10.1016/j.jacc.2024.02.014). PubMed lists an erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277) that has no abstract, so what it corrects is not known, and the source state is corrected. The full text was not read, so this is a guideline identity with one descriptive claim. This atlas has no records yet for AMSSM, HRS, PACES or SCMR.

## Claims, with the population each applies to

## Context: Patients with hypertrophic cardiomyopathy, as covered by the 2024 multisociety guideline (AHA/ACC/AMSSM/HRS/PACES/SCMR, abstract)

Recipient: Recipient not specified; Population: Patients with hypertrophic cardiomyopathy. The abstract states no age limits and no recommendation for any group.; Care setting: Not stated in the abstract.; Geography: United States (a guideline of the American Heart Association and American College of Cardiology); the abstract names no other jurisdiction.; Life stage: The abstract states no age limits.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline).

### The abstract of the 2024 guideline on managing hypertrophic cardiomyopathy from AHA, ACC, AMSSM, HRS, PACES and SCMR says the guideline gives recommendations to help guide clinicians who manage patients with hypertrophic cardiomyopathy. It describes the condition as a common genetic heart disease that has been reported in populations worldwide. It says the earlier 2020 AHA/ACC recommendations on diagnosing and treating hypertrophic cardiomyopathy were updated with new evidence. It says a literature search ran from 14 September 2022 to 22 November 2022, and that studies published through 23 May 2023 were also considered.

- Category: Description
- Evidence stage: Guidance
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients with hypertrophic cardiomyopathy. The abstract states no age limits and no recommendation for any group.; Care setting: Not stated in the abstract.; Geography: United States (a guideline of the American Heart Association and American College of Cardiology); the abstract names no other jurisdiction.; Life stage: The abstract states no age limits.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline).
- Limitations: Only the abstract and bibliographic records were read. The full text was not read, so no recommendation, class of recommendation or level of evidence is recorded here. PubMed links a published erratum to the Circulation version (Circulation, DOI 10.1161/CIR.0000000000001277, PMID 39159227) that has no abstract, so it is not known what it corrects or whether it changes anything the abstract says. The same guideline was also published in the Journal of the American College of Cardiology (PMID 38727647), which was not used as a source. This claim describes what the abstract says the guideline covers. It is not a recommendation.
- Last checked: 2026-10-30
- Source problem: a cited source is corrected. Check the sources before relying on this claim.
- Sources:
  1. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: ArticleTitle, fragment 1 of 2. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Title of the guideline, which names the issuing societies.
  2. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: Abstract, AIM, sentence 1. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Aim of the guideline, stated in the abstract.
  3. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: Abstract, METHODS, sentence 1, fragment 1 of 3. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Literature search dates, stated in the abstract.
  4. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: Abstract, METHODS, sentence 2, fragment 1 of 2. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Later studies considered, stated in the abstract.
  5. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: Abstract, STRUCTURE, sentence 1. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Description of the condition, stated in the abstract.
  6. Supports: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (abstract and bibliographic data) fetched 2026-10-30 through NCBI E-utilities. No PMC copy is listed. Only the abstract was read. The same guideline was published in the Journal of the American College of Cardiology (PMID 38727647, DOI 10.1016/j.jacc.2024.02.014; PubMed record fetched, abstract identical in the parts quoted). PubMed links a published erratum to the Circulation version (PMID 39159227, DOI 10.1161/CIR.0000000000001277), which has no abstract, so what it corrects is not known; the source state is corrected.) <https://doi.org/10.1161/CIR.0000000000001250>
     Locator: Abstract, STRUCTURE, sentence 2, fragment 1 of 2. Retrieved 2026-10-30T19:45:51Z. Source state: Corrected. Version fingerprint: f7985cdccab87bbda0411d780d69d8e775b8970ddb3ffd17892bedc81ce5bf6a.
     How it applies: Update of the 2020 guideline, stated in the abstract.
  7. Background: Correction to: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (bibliographic data only; PubMed holds no abstract) fetched 2026-10-30 through NCBI E-utilities. It is a published erratum. What it corrects was not read.) <https://doi.org/10.1161/CIR.0000000000001277>
     Locator: ArticleTitle, fragment 1 of 2. Retrieved 2026-10-30T19:45:50Z. Source state: Current. Version fingerprint: d6bc138f6443e40caf0e7b6e7bb7b3207be19a86c65fbc8d77db8e29aa39a078.
     How it applies: Title of the published erratum.
  8. Background: Correction to: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (Publication, edition PubMed record (bibliographic data only; PubMed holds no abstract) fetched 2026-10-30 through NCBI E-utilities. It is a published erratum. What it corrects was not read.) <https://doi.org/10.1161/CIR.0000000000001277>
     Locator: PublicationType. Retrieved 2026-10-30T19:45:50Z. Source state: Current. Version fingerprint: d6bc138f6443e40caf0e7b6e7bb7b3207be19a86c65fbc8d77db8e29aa39a078.
     How it applies: Type of the erratum record.

## Connected pages

- Co-issuer, with the American Heart Association and four other societies: American College of Cardiology (`core:acc`)
- Co-issuer, with the American College of Cardiology and four other societies: American Heart Association (`core:aha`)

## Provenance

Content hash: df9635f0f99678f3529e7af8ed3d52cdacbac98a4ea396044bd0b383bb17b86d
Last substantive edit: 2026-10-30
Evidence last checked: 2026-10-30
